AlphaStocks
5.8
Consider Buy

Biolife Solutions Inc (BLFS)

As of Sep 20, 2026, Biolife Solutions Inc (BLFS) scores 5.8/10 on AlphaStocks' five-model composite, #62 of 168 Health Care stocks.

Health Care / Health Care Supplies

S&P SmallCap 600

$36.67

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#62out of 168 in Health Care

Is BIOLIFE SOLUTIONS INC a Good Investment in 2026?

BIOLIFE SOLUTIONS INC (BLFS) scores 5.8 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates BIOLIFE SOLUTIONS INC as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -1.2% · ROC -13%. BIOLIFE SOLUTIONS INC ranks #62 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-0.9Market Cap2B

Valuation

Currently unprofitable — fair value estimate not available.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -1.2% · ROC -13%

Frequently Asked Questions

Is BIOLIFE SOLUTIONS INC (BLFS) a good investment?
As of Sep 20, 2026, Biolife Solutions Inc (BLFS) scores 5.8/10 on AlphaStocks' five-model composite, #62 of 168 Health Care stocks. That is a middle-of-the-pack score with no strong signal either way. Currently unprofitable — fair value estimate not available.
What is BIOLIFE SOLUTIONS INC's Piotroski F-Score?
BIOLIFE SOLUTIONS INC's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is BLFS overvalued or undervalued?
A precise fair value estimate is not available for BLFS. Currently unprofitable — fair value estimate not available.
How does BLFS compare to other Health Care stocks?
BIOLIFE SOLUTIONS INC ranks #62 out of 168 stocks in the Health Care sector, placing it in the top 37% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about BLFS?
AlphaStocks evaluates BLFS using five proven investment models. Piotroski: Strong; Buffett: Caution; Graham: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.8/10.

Similar Stocks

WSTLNTHMMSI

Compare BLFS with

BLFS vs WSTBLFS vs LNTHBLFS vs MMSI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer